过去一年中添加的文章,按日期排序

[PDF][PDF] Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer

市橋淳, イチハシアツシ - ompu.repo.nii.ac.jp
10 天前 - … Only 30% of node-positive nmUBC patients survive 3 years following RC and
bilateral … chemotherapy to RC has demonstrated improved survival outcomes for node-positive

Surgery and Stereotactic Radiotherapy for Stage I Small Cell Lung Carcinoma: A 25-Year Experience”

LA Robinson, T Tanvetyanon, NA Robinson… - Clinical Lung Cancer, 2024 - Elsevier
32 天前 - adjuvant chemotherapy in our patient population offers a … of the N2 node positive
patients were known preoperatively … node positive patients underwent adjuvant chemotherapy

Patient-reported outcomes in N1 breast cancer: A phase III trial comparing whole-breast to whole-breast plus regional irradiation after taxane-based chemotherapy  …

N Kim, W Park, H Kim, WK Cho, YH Park, SJ Ahn… - 2024 - ascopubs.org
41 天前 - node-positive or pN1 breast cancer, yet its impact in the context of modern taxane-based
adjuvant chemotherapy … terms of disease-free survival between standard whole-breast …

Clinical outcomes and prognostic factors in epithelial-myoepithelial carcinoma (EMC) of the breast.

U Joshi, P Budhathoki, S Gaire, C Niu, N Neupane… - 2024 - ascopubs.org
41 天前 - … Administration of chemotherapy or radiation was associated with improved OS in
tumors >5 … objective efficacy of systemic treatment in lymph node positive and metastatic EMC. …

… patients (pts) with hormone receptor positive (HR+), HER2-negative, node-positive breast cancer most likely to benefit from adjuvant chemotherapy in SWOG S1007 …

K Kalinsky, WE Barlow, HB Pathak, JR Gralow… - 2024 - ascopubs.org
41 天前 - … There was no invasive disease-free survival (IDFS) benefit for CET … an IDFS
improvement compared to ET (HR=0.60; 95% 0.43-0.83). The objective was to further refine patient

Adjuvant chemotherapy guided by an integrated mRNA–lncRNA signature in triple-negative breast cancer (BCTOP-T-A01): A randomized, open-label, multicenter …

M He, YZ Jiang, Y Gong, L Fan, XY Liu, XH Zeng… - 2024 - ascopubs.org
41 天前 - patients aged 18-70 years with early TNBC after definitive surgery (histologically
confirmed axillary lymph node-positivepatients were randomized (1:1) to receive an intensive …

The preliminary efficacy and safety results of neoadjuvant phase 2 study of penpulimab combined with taxanes and carboplatin in triple-negative breast cancer …

W Yan, G Zhang, L Yuan, D Ma, Y Liang, Y Zhang… - 2024 - ascopubs.org
42 天前 - … showed the pCR rate of patients who were diagnosed initially to be lymph node
negative was 75.0% (6/8), higher than that of patients who were lymph node positive (44.4%; 4/…

Trends and outcomes in patients receiving neoadjuvant chemotherapy for breast cancer in Ontario: A population-based study.

M Castelo, L Nguyen, A Roberts - 2024 - ascopubs.org
42 天前 - … Most patients were clinically node-positive (2,736; 71.9%)… There was a significant
increase in the number of patients … ), with a greater increase among patients with TNBC or …

Impact of adjuvant chemotherapy on outcomes after curative-intent surgery for biliary tract cancer: A 10-year retrospective single-center study.

R Levy, S Zhen, C Zhang, JY Moon, F Bteich, C Kuang - 2024 - ascopubs.org
42 天前 - associated with 1.88-2.78 times higher relapse risk. Surprisingly, receipt of adjuvant
chemotherapy was associated … The association between receipt of adjuvant chemotherapy

The effectiveness of adequate lymphadenectomy in radically-resected cases with pathologically-confirmed node-negative biliary tract cancers: A SEER-based …

TR Lv, HJ Lin, HJ Hu, FY Li - Current Problems in Surgery, 2024 - Elsevier
43 天前 - … suggesting that immune-based combinations are linked to improved long-term survival.
… , as it provides a survival benefit for radically-resected cases with node-positive disease …